Liminatus Pharma, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| LIMNW | PMRA.F | RCUS | ATORX.ST | BIIB | MGNX | |
|---|---|---|---|---|---|---|
| Market cap | — | 1.17B | 2.43B | 37.82M | 37.61B | 147.15M |
| P/E (TTM) | — | 17.3 | — | — | 110.2 | — |
| Forward P/E | — | — | -6.2 | -0.1 | 15.6 | -1.6 |
| Price/book | 0.1 | 5.0 | 3.8 | 0.3 | 2.0 | 3.4 |
| Dividend yield | — | 1.54% | — | — | — | — |
| 1-year change | — | −9.28% | −1.28% | −99.44% | +62.35% | +69.85% |
| Today | 0.00% | +6.01% | +2.12% | −0.93% | +2.22% | −0.86% |
The closest companies by business. Prices may be delayed up to 15 min.
Latest news
All LIMNW news ›Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. The Company intends to use the net proceeds from the ... 17, 2026 (GLOBE NEWSWIRE) --…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- markets.financialcontent.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.